Real-world evidence of treatment intensification in people with T2D inadequately controlled on GLP-1 RAs

Insights from Prof. Timothy Baily on new Real-world evidence in DELIVER G study and the implications of adding Toujeo® to people with T2D inadequately controlled on GLP-RAs.

Having an inquiry about this content? Contact Diabetes Medical Scientific Liaison.

MAT-BH-2100740/V1/October 2021